Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to -$1.9 million.

  • NeuroPace's Free Cash Flow fell 373.93% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.5 million, marking a year-over-year increase of 157.74%. This contributed to the annual value of -$18.3 million for FY2024, which is 814.63% up from last year.
  • According to the latest figures from Q3 2025, NeuroPace's Free Cash Flow is -$1.9 million, which was down 373.93% from -$2.2 million recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Free Cash Flow ranged from a high of -$1.9 million in Q3 2024 and a low of -$11.7 million during Q1 2022
  • Over the past 5 years, NeuroPace's median Free Cash Flow value was -$6.0 million (recorded in 2021), while the average stood at -$5.9 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first crashed by 9604.76% in 2022, then skyrocketed by 6681.04% in 2023.
  • Over the past 5 years, NeuroPace's Free Cash Flow (Quarter) stood at -$8.4 million in 2021, then rose by 4.52% to -$8.0 million in 2022, then surged by 58.21% to -$3.3 million in 2023, then crashed by 43.65% to -$4.8 million in 2024, then skyrocketed by 59.44% to -$1.9 million in 2025.
  • Its Free Cash Flow was -$1.9 million in Q3 2025, compared to -$2.2 million in Q2 2025 and -$7.6 million in Q1 2025.